MPLT Latest Press Releases

-- November 9, 2026 --

MapLight Therapeutics to Participate in Upcoming Investor Conference Globe Newswire 4:05 PM

-- October 6, 2026 --

MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics Globe Newswire 7:00 AM

-- September 9, 2026 --

MapLight Therapeutics to Participate in Upcoming Investor Conference Globe Newswire 7:00 AM

-- August 13, 2026 --

MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

MapLight Therapeutics Announces $150 Million Private Placement Financing Globe Newswire 9:10 AM

-- July 27, 2026 --

MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law Business Wire 11:57 AM

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia Globe Newswire 7:00 AM

-- June 24, 2026 --

MapLight Therapeutics Announces Changes to Board of Directors Globe Newswire 7:00 AM

-- June 22, 2026 --

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes